Nuzenio

How Axsome Therapeutics

How Axsome Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Axsome Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:03:42 GMTAxsome Therapeutics Q2 Loss Widens, Revenue Increases - MoomooMoomoo · Mon, 10 Aug 2026 11:56:40 GMTAxsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:53 GMTAxsome Therapeutics (NASDAQ:AXSM): What Could Today’s Update Reveal About Commercial Growth And Pipeline Breadth? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 08:46:00 GMTHow Axsome Therapeutics Inc. (AXSM) Affects Rotational Strategy Timing - Stock Traders DailyStock Traders Daily · Sun, 09 Aug 2026 02:16:02 GMTInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $9,541,298.04 in Stock - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:41 GMTAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 4,660 Shares - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:40 GMTAxsome Therapeutics’ Q4 Numbers Beat Wall Street Expectations: Analyst Sees Over 23% Upside For Stock - StocktwitsStocktwits · Fri, 07 Aug 2026 06:42:28 GMT

Timeline

Mon, 10 Aug 2026 13:03:42 GMTAxsome Therapeutics Q2 Earnings Call Highlights - Yahoo Finance
Mon, 10 Aug 2026 11:56:40 GMTAxsome Therapeutics Q2 Loss Widens, Revenue Increases - Moomoo
Mon, 10 Aug 2026 11:19:53 GMTAxsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Mon, 10 Aug 2026 08:46:00 GMTAxsome Therapeutics (NASDAQ:AXSM): What Could Today’s Update Reveal About Commercial Growth And Pipeline Breadth? - Kalkine Media
Sun, 09 Aug 2026 02:16:02 GMTHow Axsome Therapeutics Inc. (AXSM) Affects Rotational Strategy Timing - Stock Traders Daily
Fri, 07 Aug 2026 23:12:41 GMTInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $9,541,298.04 in Stock - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for How Axsome Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.